Patent ID: 9061019
Filing Date: 2015-06-23
Classification: A61K,A61P,C07D,Y02A

Abstract:
1. A pharmaceutical composition comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of a salt represented by Formula II: and aspirin, wherein the salt is a crystalline polymorph comprising a powder X-ray diffraction pattern having at least four characteristic peak locations selected from 4.9±0.2, 9.7±0.2, 13.8±0.2, 14.1±0.2, 15.2±0.2, 17.6±0.2, 18.5±0.2, 20.8±0.2, 21.6±0.2, 22.7±0.2, 24.1±0.2, 26.3±0.2, 26.8±0.2 degrees 2θ.